Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma

por Miller, Aubrey L., Garcia, Patrick L., Gamblin, Tracy L., Vance, Rebecca B., Yoon, Karina J.
Publicado 2020

The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer

por Miller, Aubrey L., Garcia, Patrick L., Fehling, Samuel C., Gamblin, Tracy L., Vance, Rebecca B., Council, Leona N., Chen, Dongquan, Yang, Eddy S., van Waardenburg, Robert C. A. M., Yoon, Karina J.
Publicado 2021